| Literature DB >> 30567572 |
Mohammad Alkhalil1,2, Alessandra Borlotti1, Giovanni Luigi De Maria3, Lisa Gaughran1, Jeremy Langrish3, Andrew Lucking3, Vanessa Ferreira4, Rajesh K Kharbanda3, Adrian P Banning3, Keith M Channon3,2, Erica Dall'Armellina1, Robin P Choudhury5,6,7.
Abstract
BACKGROUND: It has recently been suggested that myocardial oedema follows a bimodal pattern early post ST-segment elevation myocardial infarction (STEMI). Yet, water content, quantified using tissue desiccation, did not return to normal values unlike oedema quantified by cardiovascular magnetic resonance (CMR) imaging. We studied the temporal changes in the extent and intensity of injured myocardium using T1-mapping technique within the first week after STEMI.Entities:
Keywords: Area at risk; STEMI; T1-mapping
Mesh:
Substances:
Year: 2018 PMID: 30567572 PMCID: PMC6300907 DOI: 10.1186/s12968-018-0506-3
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Study flow chart. Patients presenting with ST elevation myocardial infarction (STEMI) and occluded vessel were prospectively recruited to either temporal changes cohort or single scan cohort, depending on CMR feasibility within 3 h post stent implantation
Clinical characteristics of included patients, stratified according to the number of acquired CMR scans
| Patients characteristics | Temporal change cohort ( | Single scan cohort ( | |
|---|---|---|---|
| Age(a) | 60 ± 11 | 56 ± 8 | 0.26 |
| Male gender(c) | 27 (90%) | 16 (100%) | 0.54 |
| Hypertension(c) | 11 (37%) | 4 (25%) | 0.42 |
| Dyslipidaemia(c) | 10 (33%) | 6 (38%) | 0.77 |
| Active smoking(c) | 9 (30%) | 2 (13%) | 0.19 |
| Diabetes(c) | 2 (7%) | 1 (7%) | 1.0 |
| Ischaemia time(b) (mins) | 188 (149–292) | 165 (102–251) | 0.21 |
| Systolic pressure(a) | 124 ± 27 | 131 ± 24 | 0.40 |
| Diastolic pressure(a) | 75 ± 16 | 80 ± 12 | 0.29 |
| Preloading clopidogrel(c) | 21 (70%) | 10 (63%) | 0.61 |
| Anterior infarct(c) | 8 (27%) | 8 (50%) | 0.19 |
| Thrombectomy use(c) | 19 (63%) | 8 (50%) | 0.38 |
| Glycoprotein IIb/IIIa inhibitors(c) | 5 (17%) | 3 (19%) | 0.86 |
| Stent length(b) (mm) | 28 (22–32) | 26 (20–30) | 0.49 |
| Stent diameter(b) (mm) | 3.5 (3.4–4) | 3.5 (3 4) | 0.27 |
| Final TIMI III flow(c) | 25 (83%) | 13 (81%) | 1.0 |
Data are presented as (a) mean ± SD, (b) median & IQR, (c) total number and proportion, TIMI (thrombolysis in myocardial infarction)
24 h CMR characteristics of included patients in each cohort
| Patients characteristics | Temporal change cohort ( | Single scan cohort ( | |
|---|---|---|---|
| End Diastolic Volume (EDV)(a) (ml) | 168 ± 38 | 177 ± 36 | 0.42 |
| End Systolic Volume (ESV)(a) (ml) | 88 ± 33 | 85 ± 24 | 0.73 |
| Ejection Fraction (EF)(a) | 48 ± 11 | 52 ± 8 | 0.27 |
| Area At Risk (AAR)(a) (using T1 mapping) | 38.5 ± 15 | 38.0 ± 14 | 0.92 |
| Late Gadolinium Enhancement (LGE) (LV %)(b) | 21 (17–33) | 23 (13–32) | 0.72 |
| Microvascular Obstruction (MVO) (LV %)(b) | 1.0 (0–6.0) | 0.7 (0–4.3) | 0.76 |
| Incidence of MVO(c) | 15 (50%) | 8 (50%) | 1.0 |
| Myocardial Salvage Index (MSI) (LV %)(b) | 34 (22–57) | 40 (30–53) | 0.45 |
Parameter was calculated from all LV slices. Data are presented as (a) mean ±SD, (b) median & IQR, (c) total number and proportion
Dynamic changes of injured and remote myocardium within the first week following STEMI
| Studied myocardium | Reperfusion time | Pairwise comparison ( | ||||
|---|---|---|---|---|---|---|
| < 3 h | 24 h | 6 days | A* | B* | C* | |
| T1 relaxation time (inc core) (b) | 1404 ± 76 | 1345 ± 49 | 1384 ± 77 | < 0.001 | 0.81 | 0.046 |
| T1 relaxation time (remote) (b)
| 1189 ± 16 | 1182 ± 27 | 1181 ± 19 | 0.14 | 0.004 | 1.0 |
| T1 relaxation time (exc core) (b) | 1406 ± 71 | 1353 ± 55 | 1398 ± 67 | < 0.001 | 1.0 | 0.001 |
| Injured myocardium (AAR, LV %) on T1 map(b) | 37 ± 11 | 38 ± 11 | 42 ± 9 | 1.0 | 0.001 | 0.019 |
| T1 core area(b) (mm2) | 0.15 ± 1.14 | 1.1 ± 1.14 | 0.84 ± 1.15 | < 0.001 | 0.028 | 0.99 |
| T1 core prevalence(c), a | 4 (13%) | 15 (50%) | 9 (41%) | – | – | – |
aP value is not presented because generalised linear mixed-effects model does not support analysis for categorical data. Data are presented as (b) mean ± SD, (c) total number and proportion. * A (comparison between < 3 & 24 h), B (comparison between < 3 h & 6 days), and C (comparison between 24 h & 6 days)
Fig. 2Bimodal changes of T1 relaxation time. Panel a short-axis T1 maps in a patient with inferior ischaemic injury (black arrow) acquired at three time points post STEMI presentation. The magnitude of change in native T1 value within the area at risk (AAR) (contoured in black) is illustrated against a colour scale map. Panel b T1 relaxation time showed significant attenuation of oedematous reaction in the injured myocardium after 24 h and returns to previous level at 6 days (blue lines representing mean +/− 2 standard error). Changes within remote myocardium over time are illustrated in black lines (mean +/− 2 standard error). Panel c excluding central area with low T1 values (T1-core), T1 relaxation time was compared serially. The deferred wave of oedematous reaction was more prominent with significant difference between 24 h and 6 days (blue lines representing mean +/− 2 standard error)
Fig. 3Changes in extent of oedema. Panel a AAR, quantified using T1 mapping sequence, did not undergo significant changes within 24 h. There was significant increase in extent of oedema at 6 days mirroring increase in T1 relaxation time (mean +/− 2 standard error). Panel b pairwise comparison between injured myocardium in T2-weighted and T1 mapping (mean +/− 2 standard error)
Dynamic changes of LGE, MVO and IMH within the first week following STEMI
| Time from reperfusion | Pairwise comparison ( | |||||
|---|---|---|---|---|---|---|
| < 3 h | 24 h | 6 days | A* | B* | C* | |
| Ejection fraction (EF) (%) | 49 ± 11 | 48 ± 11 | 51 ± 9 | 0.66 | 0.45 | 0.21 |
| End Diastolic Volume (EDV) ( | 162 ± 33 | 168 ± 33 | 177 ± 29 | 0.11 | 0.001 | 0.015 |
| End Systolic Volume (ESV) | 83 ± 27 | 89 ± 27 | 89 ± 24 | 0.085 | 0.057 | 1.0 |
| Late gadolinium enhancement (LGE) (LV %) | 27 ± 16 | 26 ± 16 | 27 ± 19 | 1.0 | 0.99 | 0.87 |
| Microvascular obstruction (MVO) (LV %) | 4.0 ± 4.9 | 4.1 ± 6.0 | 2.4 ± 3.4 | 1.0 | 0.02 | 0.011 |
| MVO prevalence (n, %) | 11 (44%) | 17 (56%) | 12 (55%) | – | – | – |
| Intra-myocardial haemorrhage (IMH) | 0.7 ± 1.6 | 1.4 ± 1.6 | 1.1 ± 1.4 | 0.012 | 0.46 | 0.69 |
| IMH prevalence (n, %) | 9 (36%) | 14 (47%) | 10 (45%) | – | – | – |
All data are presented as mean ± SD, * A (comparison between < 3 & 24 h), B (comparison between < 3 h & 6 days), and C (comparison between 24 h & 6 days)
Fig. 4Changes in T1 core, LGE, MVO and IMH. Development of T1 core (yellow arrow), area of low T1 value within injured myocardium that progressed over time. The extent of late gadolinium enhancement (LGE) was comparable across time points with early peak of microvascular obstruction (MVO) (red arrows) compared to more lagged peak of intramyocardial haemorrhage (IMH) (contoured in black)